---
title: Gilead to Test Remdesivir Delivered Through Inhalation
description: Gilead to Test Remdesivir Delivered Through Inhalation
---

[News ](https://www.yourway.com/news)

# [Gilead to Test Remdesivir Delivered Through Inhalation](https://www.yourway.com/news/gilead-to-test-remdesivir-delivered-through-inhalation)

 Written by [Yourway](https://www.yourway.com/news/author/yourway) | July 3, 2020

Gilead will begin [testing](https://www.nytimes.com/2020/06/22/health/gilead-remdesivir-coronavirus-nebulizer.html) an inhaled version of their leading COVID-19 treatment, Remdesivir. It is currently administered to patients intravenously in a hospital setting, though delivery via a nebulizer is decidedly more patient-centric. Regardless of dosage form, Yourway has the means to transport, store, and ship even the most sensitive clinical trial samples globally.

[View full post](https://www.yourway.com/news/gilead-to-test-remdesivir-delivered-through-inhalation)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Yourway"
  },
  "dateModified" : "2020-07-03T09:30:00.429Z",
  "datePublished" : "2020-07-03T09:30:00Z",
  "headline" : "Gilead to Test Remdesivir Delivered Through Inhalation",
  "image" : {
    "@type" : "ImageObject",
    "height" : 2160,
    "url" : "https://f.hubspotusercontent30.net/hubfs/5402331/iStock-1067806062-1.jpg",
    "width" : 3840
  },
  "mainEntityOfPage" : "https://www.yourway.com/news/gilead-to-test-remdesivir-delivered-through-inhalation",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "News"
  }
}
```